Need Help?
Contact Us

IT TAKES COLLABORATION TO MAKE SCIENCE MORE MEANINGFUL

  • News Releases

    Voluntary Recall of Chariot™ Guiding Sheath

    MARLBOROUGH, Mass., Dec. 9, 2015 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has voluntarily recalled the Chariot Guiding Sheath globally. These devices are intended for the introduction of interventional devices during peripheral vascular procedures, and were recalled on November 19th due to the risk of shaft separation. The U.S. Food and Drug Administration (FDA) has classified the action as a Class-1 recall.

    To date, Boston Scientific has received fourteen complaints for shaft separation, four of which involved separation of the distal shaft.  These events occurred during device preparation or use. The most severe outcome of this failure is embolism of device fragments, which could lead to obstruction of blood flow or additional intervention to remove a device fragment.  Obstruction of blood flow can result in injuries such as stroke, kidney damage or damage to the intestines or limbs. To date, no permanent injuries or patient deaths have been reported.

    All affected healthcare facilities were previously advised to immediately discontinue use of affected devices and return unused Chariot Guiding Sheaths to Boston Scientific.  Additionally, physicians are encouraged to contact all patients who have undergone procedures involving Chariot to confirm their post-procedure status, as device shaft separation and embolized fragments may not have been recognized at the time of the procedure.

    The recall affects all UPNs of the Chariot Guiding Sheaths. Customers have been advised to remove the affected recalled product from inventory and return it to Boston Scientific.

     

    H74939277645110

    H74939277745110

    H74939277845110

    H74939277645220

    H74939277765120

    H74939277690210

    H74939277665110

    H74939277790110

    H74939277645120

    H74939277865120

    H74939277690220

    H74939277690110

    H74939277865110

    H74939277745120

    H74939277890120

    H74939277845210

    H74939277765110

    H74939277545210

    H74939277790210

    H74939277845120

    H74939277745210

    H74939277545110

    H74939277790220

    H74939277790120

    H74939277745220

    H74939277645210

    H74939277690120

    H74939277665120

    H74939277890110

     

     

    Physicians and healthcare facilities can direct questions to their Boston Scientific representative or by calling 1-800-811-3211. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

    or

    • Health care professionals and consumers may report serious adverse events or product quality problems with the use of this product to Boston Scientific by calling 1-800-811-3211 and to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or phone.

    CONTACT: 
    Tom Keppeler
    Corporate Communications
    Boston Scientific Corporation
    +1 (508) 683-6585
    Thomas.Keppeler@bsci.com

    Susie Lisa, CFA
    Investor Relations
    Boston Scientific Corporation
    +1 (508) 683-5565
    investor_relations@bsci.com

    SOURCE Boston Scientific